X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology and hepatology (44) 44
humans (34) 34
female (30) 30
male (30) 30
index medicus (28) 28
gastroenterology & hepatology (22) 22
middle aged (22) 22
adult (21) 21
treatment outcome (20) 20
double-blind method (18) 18
inflammatory-bowel-disease (17) 17
adalimumab (16) 16
cardiovascular (15) 15
ulcerative colitis (14) 14
aged (11) 11
crohn disease - drug therapy (11) 11
severity of illness index (11) 11
adolescent (10) 10
efficacy (10) 10
inflammatory bowel disease (10) 10
remission induction (10) 10
therapy (10) 10
anti-inflammatory agents - therapeutic use (9) 9
colitis, ulcerative - drug therapy (9) 9
human necessities (9) 9
hygiene (9) 9
medical or veterinary science (9) 9
preparations for medical, dental, or toilet purposes (9) 9
young adult (9) 9
care and treatment (8) 8
drug therapy, combination (8) 8
medicine & public health (8) 8
remission (8) 8
abridged index medicus (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
crohns-disease (7) 7
infliximab (7) 7
adalimumab - administration & dosage (6) 6
dose-response relationship, drug (6) 6
endoscopy (6) 6
gastroenterology (6) 6
maintenance (6) 6
management (6) 6
pharmacology & pharmacy (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
adalimumab - therapeutic use (5) 5
clinical remission (5) 5
crohn's disease (5) 5
guidelines (5) 5
medical colleges (5) 5
monoclonal antibodies (5) 5
niacin (5) 5
original (5) 5
prospective studies (5) 5
quality of life (5) 5
safety (5) 5
time factors (5) 5
trial (5) 5
tumor necrosis factor-alpha - antagonists & inhibitors (5) 5
aged, 80 and over (4) 4
anti-inflammatory agents - administration & dosage (4) 4
anti-inflammatory agents - adverse effects (4) 4
anti-inflammatory agents - pharmacokinetics (4) 4
anti-tumor necrosis factor (4) 4
cardiac & cardiovascular systems (4) 4
child (4) 4
clinical trials (4) 4
corticosteroids (4) 4
delayed-action preparations (4) 4
diagnosis (4) 4
dyslipidemia (4) 4
dyslipidemias - drug therapy (4) 4
follow-up studies (4) 4
hepatology (4) 4
japan (4) 4
niacin - therapeutic use (4) 4
original article (4) 4
patients (4) 4
simvastatin (4) 4
adalimumab - adverse effects (3) 3
calculating (3) 3
cardiotonic agents - therapeutic use (3) 3
children (3) 3
complications and side effects (3) 3
computing (3) 3
counting (3) 3
crohn disease - blood (3) 3
crohn disease - diagnosis (3) 3
crohn disease - pathology (3) 3
crohns disease (3) 3
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (3) 3
drug administration schedule (3) 3
drug therapy (3) 3
endoscopy, gastrointestinal (3) 3
flushing - chemically induced (3) 3
heart failure - drug therapy (3) 3
hydrazones - therapeutic use (3) 3
hypolipidemic agents - therapeutic use (3) 3
identification (3) 3
increased risk (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Digestive Diseases and Sciences, ISSN 0163-2116, 5/2019, Volume 64, Issue 5, pp. 1142 - 1149
One of the therapy goals for Crohn’s disease (CD) is glucocorticoid-free remission. Studies have shown care setting-specific variations in inflammatory bowel... 
Biochemistry, general | Medicine & Public Health | Glucocorticoids | Physician-reported outcomes | Hepatology | Gastroenterology | Oncology | Patient-reported outcomes | Transplant Surgery | Crohn’s disease | Quality of life
Journal Article
The Lancet, ISSN 0140-6736, 12/2017, Volume 390, Issue 10114, pp. 2779 - 2789
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 2/2014, Volume 49, Issue 2, pp. 283 - 294
Journal Article
Journal Article
Intestinal research (Intest Res), ISSN 1598-9100, 2016, Volume 14, Issue 2, p. 152
Background/Aims: This was a Phase 2 study (NCT02015793) to evaluate the pharmacokinetics, safety, and efficacy of adalimumab in Chinese patients with Crohn`s... 
Crohn disease | Anti-tumor necrosis factor | Adalimumab
Journal Article
Journal Article
DIGESTIVE DISEASES AND SCIENCES, ISSN 0163-2116, 05/2019, Volume 64, Issue 5, pp. 1142 - 1149
Journal Article
18.